메뉴 건너뛰기




Volumn 105, Issue 3, 2011, Pages 175-182

Enhancement of cutaneous immune response to bacterial infection after low-level light therapy with 1072 nm infrared light: A preliminary study

Author keywords

1072 nm; Antibacterial; LED; Low level light therapy; Photobiomodulation; VEGF

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1BETA; INTERLEUKIN 6; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; TOLL LIKE RECEPTOR 2; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

EID: 80855132682     PISSN: 10111344     EISSN: 18732682     Source Type: Journal    
DOI: 10.1016/j.jphotobiol.2011.08.009     Document Type: Article
Times cited : (29)

References (43)
  • 1
    • 84948590512 scopus 로고
    • Photobiological fundamentals of low-power laser therapy
    • T.I. Karu Photobiological fundamentals of low-power laser therapy J. Quantum Electron. 23 1987 1703 1717
    • (1987) J. Quantum Electron. , vol.23 , pp. 1703-1717
    • Karu, T.I.1
  • 2
    • 0033103853 scopus 로고    scopus 로고
    • Primary and secondary mechanisms of action of visible to near-IR radiation on cells
    • DOI 10.1016/S1011-1344(98)00219-X, PII S101113449800219X
    • T. Karu Primary and secondary mechanisms of action of visible to near-IR radiation on cells J. Photochem. Photobiol. B, Biol. 49 1999 1 17 (Pubitemid 29229670)
    • (1999) Journal of Photochemistry and Photobiology B: Biology , vol.49 , Issue.1 , pp. 1-17
    • Karu, T.1
  • 9
    • 0035058566 scopus 로고    scopus 로고
    • A pilot study of treatment of herpes labialis with 1072 nm narrow waveband light
    • DOI 10.1046/j.1365-2230.2001.00783.x
    • G. Dougal, and P. Kelly A pilot study of treatment of herpes labialis with 1072 nm narrow waveband light Clin. Exp. Dermatol. 26 2001 149 154 (Pubitemid 32275706)
    • (2001) Clinical and Experimental Dermatology , vol.26 , Issue.2 , pp. 149-154
    • Dougal, G.1    Kelly, P.2
  • 10
    • 33746135616 scopus 로고    scopus 로고
    • A randomised double-blind study comparing the effect of 1072-nm light against placebo for the treatment of herpes labialis
    • DOI 10.1111/j.1365-2230.2006.02191.x
    • G. Hargate A randomised double-blind study comparing the effect of 1072-nm light against placebo for the treatment of herpes labialis Clin. Exp. Dermatol. 31 2006 638 641 (Pubitemid 44086788)
    • (2006) Clinical and Experimental Dermatology , vol.31 , Issue.5 , pp. 638-641
    • Hargate, G.1
  • 11
    • 26444578834 scopus 로고    scopus 로고
    • Probing the differential effects of infrared light sources IR1072 and IR880 on human lymphocytes: Evidence of selective cytoprotection by IR1072
    • DOI 10.1016/j.jphotobiol.2005.05.005, PII S1011134405001077
    • A. Bradford, A. Barlow, and P.L. Chazot Probing the differential effects of infrared light sources IR1072 and IR880 on human lymphocytes: evidence of selective cytoprotection by IR1072 J. Photochem. Photobiol. B 81 2005 9 14 (Pubitemid 41435266)
    • (2005) Journal of Photochemistry and Photobiology B: Biology , vol.81 , Issue.1 , pp. 9-14
    • Bradford, A.1    Barlow, A.2    Chazot, P.L.3
  • 12
    • 23044439331 scopus 로고    scopus 로고
    • Establishment of a superficial skin infection model in mice by using Staphylococcus aureus and Streptococcus pyogenes
    • DOI 10.1128/AAC.49.8.3435-3441.2005
    • E. Kugelberg, T. Norstrom, T.K. Petersen, T. Duvold, D.I. Andersson, and D. Hughes Establishment of a superficial skin infection model in mice by using Staphylococcus aureus and streptococcus pyogenes Antimicrob. Agents Chemother. 49 2005 3435 3441 (Pubitemid 41060593)
    • (2005) Antimicrobial Agents and Chemotherapy , vol.49 , Issue.8 , pp. 3435-3441
    • Kugelberg, E.1    Norstrom, T.2    Petersen, T.K.3    Duvold, T.4    Andersson, D.I.5    Hughes, D.6
  • 13
    • 33846955409 scopus 로고    scopus 로고
    • Photodynamic therapy: Update 2006. Part 1: Photochemistry and photobiology
    • P.G. Calzavara-Pinton, M. Venturini, and R. Sala Photodynamic therapy: update 2006. Part 1: photochemistry and photobiology Acad. Dermatol. Venereol. 21 2007 2006 293 302
    • (2006) Acad. Dermatol. Venereol. , vol.21 , Issue.2007 , pp. 293-302
    • Calzavara-Pinton, P.G.1    Venturini, M.2    Sala, R.3
  • 14
    • 0037458529 scopus 로고    scopus 로고
    • Eradication of Propionibacterium acnes by its endogenic porphyrins after illumination with high intensity blue light
    • DOI 10.1016/S0928-8244(02)00423-6, PII S0928824402004236
    • H. Ashkenazi, Z. Malik, Y. Harth, and Y. Nitzan Eradication of Propionibacterium acnes by its endogenic porphyrins after illumination with high intensity blue light FEMS Immunol. Med. Microbiol. 35 2003 17 24 (Pubitemid 36173500)
    • (2003) FEMS Immunology and Medical Microbiology , vol.35 , Issue.1 , pp. 17-24
    • Ashkenazi, H.1    Malik, Z.2    Harth, Y.3    Nitzan, Y.4
  • 16
    • 33947127545 scopus 로고    scopus 로고
    • Blue and red light combination LED phototherapy for acne vulgaris in patients with skin phototype IV
    • DOI 10.1002/lsm.20412
    • S.Y. Lee, C.E. You, and M.Y. Park Blue and red light combination LED phototherapy for acne vulgaris in patients with skin phototype IV Lasers Surg. Med. 39 2007 180 188 (Pubitemid 46411414)
    • (2007) Lasers in Surgery and Medicine , vol.39 , Issue.2 , pp. 180-188
    • Lee, S.Y.1    You, C.E.2    Park, M.Y.3
  • 18
    • 0033813246 scopus 로고    scopus 로고
    • Photodynamic therapy for acne vulgaris with topical 5-aminolevulinic acid
    • Y. Itoh, Y. Ninomiya, S. Tajima, and A. Ishibashi Photodynamic therapy for acne vulgaris with topical 5-aminolevulinic acid Arch. Dermatol. 136 2000 1093 1095
    • (2000) Arch. Dermatol. , vol.136 , pp. 1093-1095
    • Itoh, Y.1    Ninomiya, Y.2    Tajima, S.3    Ishibashi, A.4
  • 19
    • 4944227264 scopus 로고    scopus 로고
    • Topical aminolaevulinic acid-photodynamic therapy for the treatment of acne vulgaris: A study of clinical efficacy and mechanism of action
    • DOI 10.1111/j.1365-2133.2004.06110.x
    • B. Pollock, D. Turner, M. Stringer, R.A. Bojar, V. Goulden, and G.I. Stables Topical aminolaevulinic acid-photodynamic therapy for the treatment of acne vulgaris: a study of clinical efficacy and mechanism of action Br. J. Dermatol. 151 2004 616 622 (Pubitemid 39330886)
    • (2004) British Journal of Dermatology , vol.151 , Issue.3 , pp. 616-622
    • Pollock, B.1    Turner, D.2    Stringer, M.R.3    Bojar, R.A.4    Goulden, V.5    Stables, G.I.6    Cunliffe, W.J.7
  • 20
    • 65349102221 scopus 로고    scopus 로고
    • Photodynamic therapy for the treatment of cutaneous neoplasia, inflammatory disorders, and photoaging
    • E. Tierney, A. Barker, J. Ahdout, C.W. Hanke, R.L. Moy, and D.J. Kouba Photodynamic therapy for the treatment of cutaneous neoplasia, inflammatory disorders, and photoaging Dermatol. Surg. 35 2009 725 746
    • (2009) Dermatol. Surg. , vol.35 , pp. 725-746
    • Tierney, E.1    Barker, A.2    Ahdout, J.3    Hanke, C.W.4    Moy, R.L.5    Kouba, D.J.6
  • 21
    • 67849121253 scopus 로고    scopus 로고
    • Methyl aminolevulinate-PDT for actinic keratoses and superficial nonmelanoma skin cancers
    • B. Ortiz-Policarpio, and H. Lui Methyl aminolevulinate-PDT for actinic keratoses and superficial nonmelanoma skin cancers Skin Ther. Lett. 14 2009 1 3
    • (2009) Skin Ther. Lett. , vol.14 , pp. 1-3
    • Ortiz-Policarpio, B.1    Lui, H.2
  • 22
    • 56549129972 scopus 로고    scopus 로고
    • British association of dermatologists therapy guidelines and audit subcommittee and the British photodermatology group, guidelines for topical photodynamic therapy: Update
    • C.A. Morton, K.E. McKenna, and L.E. Rhodes British association of dermatologists therapy guidelines and audit subcommittee and the British photodermatology group, guidelines for topical photodynamic therapy: update Br. J. Dermatol. 159 2008 1245 1266
    • (2008) Br. J. Dermatol. , vol.159 , pp. 1245-1266
    • Morton, C.A.1    McKenna, K.E.2    Rhodes, L.E.3
  • 23
    • 33745699953 scopus 로고    scopus 로고
    • Photodynamic therapy in the treatment of microbial infections: Basic principles and perspective applications
    • G. Jori, C. Fabris, M. Soncin, S. Ferro, O. Coppellotti, and D. Dei Photodynamic therapy in the treatment of microbial infections: basic principles and perspective applications Lasers Surg. Med. 38 2006 468 481
    • (2006) Lasers Surg. Med. , vol.38 , pp. 468-481
    • Jori, G.1    Fabris, C.2    Soncin, M.3    Ferro, S.4    Coppellotti, O.5    Dei, D.6
  • 24
    • 0031821590 scopus 로고    scopus 로고
    • Photodynamic antimicrobial chemotherapy (PACT)
    • DOI 10.1093/jac/42.1.13
    • M. Wainwright Photodynamic antimicrobial chemotherapy (PACT) J. Antimicrob. Chemother. 42 1998 13 28 (Pubitemid 28356358)
    • (1998) Journal of Antimicrobial Chemotherapy , vol.42 , Issue.1 , pp. 13-28
    • Wainwright, M.1
  • 25
    • 11844268033 scopus 로고    scopus 로고
    • A comprehensive overview of photodynamic therapy in the treatment of superficial fungal infections of the skin
    • DOI 10.1016/j.jphotobiol.2004.06.006, PII S1011134404001241
    • P.G. Calzavara-Pinton, M. Venturini, and R. Sala A comprehensive overview of photodynamic therapy in the treatment of superficial fungal infections of the skin J. Photochem. Photobiol. B 78 2005 1 6 (Pubitemid 40090155)
    • (2005) Journal of Photochemistry and Photobiology B: Biology , vol.78 , Issue.1 , pp. 1-6
    • Calzavara-Pinton, P.G.1    Venturini, M.2    Sala, R.3
  • 26
    • 22244439504 scopus 로고    scopus 로고
    • Recognition of Staphylococcus aureus by the innate immune system
    • DOI 10.1128/CMR.18.3.521-540.2005
    • B. Fournier, and D.J. Philpott Recognition of Staphylococcus aureus by the innate immune system Clin. Microbiol. Rev. 18 2005 521 540 (Pubitemid 40995114)
    • (2005) Clinical Microbiology Reviews , vol.18 , Issue.3 , pp. 521-540
    • Fournier, B.1    Philpott, D.J.2
  • 28
    • 2542478053 scopus 로고    scopus 로고
    • Wound healing: An overview of acute, fibrotic and delayed healing
    • d1-504
    • R.F. Diegelmann, and M.C. Evans Wound healing: an overview of acute, fibrotic and delayed healing Front Biosci. 9 2004 283 289 (Pubitemid 38925460)
    • (2004) Frontiers in Bioscience , vol.9 , pp. 283-289
    • Diegelmann, R.F.1    Evans, M.C.2
  • 29
    • 78049523518 scopus 로고    scopus 로고
    • Responding to infection and apoptosis - A task for TH17 cells
    • C.F. Brereton, and J.M. Blander Responding to infection and apoptosis - a task for TH17 cells Ann. N.Y. Acad. Sci. 1209 2010 56 67
    • (2010) Ann. N.Y. Acad. Sci. , vol.1209 , pp. 56-67
    • Brereton, C.F.1    Blander, J.M.2
  • 30
    • 42649108339 scopus 로고    scopus 로고
    • Monocyte-mediated defense against microbial pathogens
    • DOI 10.1146/annurev.immunol.26.021607.090326
    • N.V. Serbina, T. Jia, T.M. Hohl, and E.G. Pamer Monocyte-mediated defense against microbial pathogens Annu. Rev. Immunol. 26 2008 421 452 (Pubitemid 351600381)
    • (2008) Annual Review of Immunology , vol.26 , pp. 421-452
    • Serbina, N.V.1    Jia, T.2    Hohl, T.M.3    Pamer, E.G.4
  • 31
    • 34548443831 scopus 로고    scopus 로고
    • Vascular endothelial growth factor receptor-2: Structure, function, intracellular signalling and therapeutic inhibition
    • DOI 10.1016/j.cellsig.2007.05.013, PII S0898656807001532
    • K. Holmes, O.L. Roberts, A.M. Thomas, and M.J. Cross Vascular endothelial growth factor receptor-2: structure, function, intracellular signaling and therapeutic inhibition Cell Signal. 19 2007 2003 2012 (Pubitemid 47354167)
    • (2007) Cellular Signalling , vol.19 , Issue.10 , pp. 2003-2012
    • Holmes, K.1    Roberts, O.L.2    Thomas, A.M.3    Cross, M.J.4
  • 33
    • 0029121235 scopus 로고
    • Angiogenesis: Mechanistic insights, neovascular disease, and therapeutic prospects
    • E.J. Battegay Angiogenesis: mechanistic insights, neovascular disease, and therapeutic prospects J. Mol. Med. 73 1995 333 346
    • (1995) J. Mol. Med. , vol.73 , pp. 333-346
    • Battegay, E.J.1
  • 34
    • 0031039243 scopus 로고    scopus 로고
    • The biology of vascular endothelial growth factor
    • DOI 10.1210/er.18.1.4
    • N. Ferrara, and T. Davis-Smyth The biology of vascular endothelial growth factor Endo Rev. 18 1997 4 25 (Pubitemid 27076453)
    • (1997) Endocrine Reviews , vol.18 , Issue.1 , pp. 4-25
    • Ferrara, N.1    Davis-Smyth, T.2
  • 36
    • 0031008458 scopus 로고    scopus 로고
    • Nitric oxide synthase lies downstream from vascular endothelial growth factor-induced but not basic fibroblast growth factor-induced angiogenesis
    • M. Ziche, L. Morbidelli, R. Choudhuri, H.T. Zhang, S. Donnini, H.J. Granger, and R. Bicknell Nitric oxide synthase lies downstream from vascular endothelial growth factor-induced but not fibroblast growth factor induced angiogenesis J. Clin. Invest. 999 1997 2625 2634 (Pubitemid 27259809)
    • (1997) Journal of Clinical Investigation , vol.99 , Issue.11 , pp. 2625-2634
    • Ziehe, M.1    Morbidelli, L.2    Choudhuri, R.3    Zhang, H.-T.4    Donnini, S.5    Granger, H.J.6    Bicknell, R.7
  • 37
    • 77956231162 scopus 로고    scopus 로고
    • Antimicrobial properties of nitric oxide and its application in antimicrobial formulations and medical devices
    • M.L. Jones, J.G. Ganopolsky, A. Labbe, C. Wahl, and S. Prakash Antimicrobial properties of nitric oxide and its application in antimicrobial formulations and medical devices Appl. Microbiol. Biotechnol. 88 2010 401 407
    • (2010) Appl. Microbiol. Biotechnol. , vol.88 , pp. 401-407
    • Jones, M.L.1    Ganopolsky, J.G.2    Labbe, A.3    Wahl, C.4    Prakash, S.5
  • 38
    • 0026688148 scopus 로고
    • Nitric oxide, a novel biologic messenger
    • C.J. Lowenstein, and S.H. Snyder Nitric oxide, a novel biologic messenger Cell 70 1992 705 707
    • (1992) Cell , vol.70 , pp. 705-707
    • Lowenstein, C.J.1    Snyder, S.H.2
  • 39
    • 0030780758 scopus 로고    scopus 로고
    • Inducible nitric oxide synthase: What difference does it make?
    • C. Nathan Perspectives series: nitric oxide and nitric oxide synthase J. Clin. Invest. 100 1997 2417 2423 (Pubitemid 27514879)
    • (1997) Journal of Clinical Investigation , vol.100 , Issue.10 , pp. 2417-2423
    • Nathan, C.1
  • 41
    • 0028917191 scopus 로고
    • Splenic B lymphocyte programmed cell death is prevented bynitric oxide release through mechanisms involving sustained Bcl-2levels
    • A.M. Genaro, S. Hortelano, A. Alvarez, C. Martinez, and L. Bosca Splenic B lymphocyte programmed cell death is prevented bynitric oxide release through mechanisms involving sustained Bcl-2levels J. Clin. Invest. 95 1995 1884 1890
    • (1995) J. Clin. Invest. , vol.95 , pp. 1884-1890
    • Genaro, A.M.1    Hortelano, S.2    Alvarez, A.3    Martinez, C.4    Bosca, L.5
  • 42
    • 0031037180 scopus 로고    scopus 로고
    • Suppression of apoptosis by nitric oxide via inhibition of interleukin-1betaconvertingenzyme (ICE)-like and cysteine protease protein(CPP)-32-like proteases
    • S. Dimmeler, J. Haendeler, M. Nehls, and A.M. Zeiher Suppression of apoptosis by nitric oxide via inhibition of interleukin-1betaconvertingenzyme (ICE)-like and cysteine protease protein(CPP)-32-like proteases J. Exp. Med. 185 1997 601 608
    • (1997) J. Exp. Med. , vol.185 , pp. 601-608
    • Dimmeler, S.1    Haendeler, J.2    Nehls, M.3    Zeiher, A.M.4
  • 43
    • 0030662226 scopus 로고    scopus 로고
    • Nitric oxide inhibits apoptosis by preventing increases in caspase-3- like activity via two distinct mechanisms
    • DOI 10.1074/jbc.272.49.31138
    • Y.M. Kim, R.V. Talanian, and T.R. Billiar Nitric oxide inhibits apoptosis by preventing increases in caspase-3-like activity via two distinct mechanisms J. Biol. Chem. 272 1997 31138 31148 (Pubitemid 27527564)
    • (1997) Journal of Biological Chemistry , vol.272 , Issue.49 , pp. 31138-31148
    • Kim, Y.-M.1    Talanian, R.V.2    Billiar, T.R.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.